BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30145856)

  • 1. [Ascites].
    Jeong SW
    Korean J Gastroenterol; 2018 Aug; 72(2):49-55. PubMed ID: 30145856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.
    Tonon M; Piano S
    Med Clin North Am; 2023 May; 107(3):505-516. PubMed ID: 37001950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites and Chronic Liver Disease in Children.
    Bolia R; Srivastava A
    Indian J Pediatr; 2024 Mar; 91(3):270-279. PubMed ID: 37310583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of refractory ascites.
    Singhal S; Baikati KK; Jabbour II; Anand S
    Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in the management of refractory cirrhotic ascites.
    Oguntona SA; Alebiosu CO
    Niger J Med; 2006; 15(3):197-202. PubMed ID: 17111742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascites in Children.
    Bavdekar A; Thakur N
    Indian J Pediatr; 2016 Nov; 83(11):1334-1340. PubMed ID: 27278239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ascites. Paracentesis as a guide.
    Habeeb KS; Herrera JL
    Postgrad Med; 1997 Jan; 101(1):191-2, 195-200. PubMed ID: 9008697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.